Impact of "Telecoaching Program" on Physical Activity in Patients With COPD

NCT02158065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2015-05-01

No results posted yet for this study

Summary

The purpose of this 3 month randomized intervention study is to investigate the additional effect of a physical activity telecoaching program on physical activity in patients with COPD, compared with usual care.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Coaching program

The coaching program consists of a (1) Step counter used as a coaching activity monitor to collect number of steps walked by the patients and (2) the Linkcare System, a mobile phone or tablet PC placed in the patient's home to collect data from the step counter. The system will set a daily activity goal for the patient based on achieved activity levels which will be measured by the step counter. Patients will also receive feedback, motivational and educational messages and direct calls from the coaching team at each institution.

Sponsors & Collaborators

  • University of Edinburgh

    collaborator OTHER
  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • University of Athens

    collaborator OTHER
  • University of Zurich

    collaborator OTHER
  • Barcelona Institute for Global Health

    collaborator OTHER
  • KU Leuven

    lead OTHER

Principal Investigators

  • Thierry Troosters, PT, PHD · KU Leuven

  • Mike Polkey, MD, PHD · Royal Brompton & Harefield NHS Foundation Trust

  • Judith Garcia-Aymerich, MD, PHD · Barcelona Institute for Global Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Belgium
  • Greece
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02158065 on ClinicalTrials.gov